Answers are grounded in this paper and cite their sources.
This editorial refers to ‘Impact of cholesterol on proinflammatory monocyte production by the bone marrow’, by L.C.A. Stiekema et al., https://doi.org/10.1093/eurheartj/ehab465. In this issue of the European Heart Journal, Stiekema et al.1 show a dual proinflammatory role for plasma LDL-cholesterol (LDL-C) levels in haematopoietic stem and progenitor cells (HSPCs) from human bone marrow (BM). LDL-C promoted myelomonocytic skewing in BM HSPCs, driving monocyte production and a monocyte inflammatory signature. A maximum tolerated dose of cholesterol-lowering therapies (LDL-C reduction ∼66%) in familial hypercholesterolaemia (FH) patients reversed myelomonocytic skewing in BM HSPCs but not the monocyte inflammatory signature. Altogether, these findings provide the first genetic evidence for the involvement of LDL-C in myelomonocytic skewing in human HSPCs and reveal how LDL-C ties chronic inflammation to cardiovascular diseases (CVD) (Graphical Abstract). It is well established that monocytosis, the expansion of blood monocytes, is associated...
No takes yet. Share an insight, caveat, or question.
Yvan‐Charvet et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: